Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 InfectionSARS-CoV-2 후 재감염 위험: SARS-CoV-2 감염 후 면역을 부여하는 데 있어 항체 반응의 역할에 대한 미국 의과대학 실습 요점을 위한 살아있는 신속한 검토Review Published on 2022-04-012022-09-11 Journal: Annals of internal medicine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI Alpha variant Asymptomatic Care Clinical practice college database Delta diagnose eligible Evidence General population Health care Health care worker health care workers Health Organization Immunity Immunocompromised index case individual individuals Infection infection risk infection with SARS-CoV-2 investigator Longitudinal studies longitudinal study Meta-analysis omicron OVID Patient physician Point Practice prevented PROSPERO protection public health Quality Racial ranged Rapid reduced risk Reinfection remained response Result review risk risk difference role SARS-CoV-2 SARS-COV-2 infection strength subgroups symptomatic symptomatic infection symptomatic infections uninfected variant variants wild-type World Health Organization [DOI] 10.7326/M21-4245 PMC 바로가기 [Article Type] Review
Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines중증급성호흡기증후군 코로나바이러스 2 벡터 및 mRNA 기반 백신 접종 후 3차 병원 직원 중 접종 후 감염Observational Study Published on 2022-04-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered administration Alpha variant analysed Antigen B.1.1.7 B.1.351 B.1.617.2 Beta Beta variant BNT162b2 Breakthrough infection breakthrough infections Care ChAdOx1 ChAdOx1-S cohort study coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 death defined Delta delta variant demographic data dose effective first dose follow-up period hazard ratio hazard ratios hospital Hospital employees Hospitalization incidence Infection mRNA mRNA-based vaccine mRNA-based vaccine. not differ Observational cohort study Participants positive PCR positive PCR test postvaccination Postvaccination infection reported respiratory specimen retrospective retrospective observational cohort study RNA SARS-CoV-2 SARS-CoV-2 vaccine second dose severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 specimen vaccination Vaccination Status Vaccine vaccine dose vaccine doses variant Vector-based vaccine Viral load virus variants [DOI] 10.1016/j.cmi.2021.11.023 PMC 바로가기 [Article Type] Observational Study
Vaccination status among patients with the need for emergency hospitalizations related to COVID-19코로나19 관련 긴급 입원이 필요한 환자의 예방접종 현황Article Published on 2022-04-012022-09-11 Journal: The American journal of emergency medicine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval age Alpha Alpha variant Analysis Characteristics chronic obstructive chronic obstructive pulmonary disease Comorbidities Comorbidity CoronaVac COVID-19 COVID-19 patients COVID-19 vaccines curiosity Delta delta variant diabetes Diabetes Mellitus died disease dose Efficacy Emergency emergency department emergency medicine emergency room Emergency use evaluate Factor Gender Hospitalization hospitalizations hypertension intensive care intensive care unit intervals lower mortality male matter moderate Mortality mortality rates multivariate logistic regression multivariate logistic regression analysis obstructive pulmonary disease Odds ratio Older other variant other variants Patient patients hospitalized performed Pfizer-BioNTech pulmonary disease reduce Regression analyses Retrospective study rRT-PCR SARS-COV-2 infection severe COVID-19 significantly significantly higher the patient the vaccine thought vaccination Vaccination Status Vaccine vaccine efficacy variant was performed women [DOI] 10.1016/j.ajem.2022.01.067 PMC 바로가기 [Article Type] Article
Increased Secondary Attack Rate among Unvaccinated Household Contacts of Coronavirus Disease 2019 Patients with Delta Variant in Japan일본에서 2019년 신종 코로나바이러스 감염증(코로나19) 환자의 예방접종을 받지 않은 가구 접촉자 중 2차 발병률 증가Article Published on 2022-03-242022-09-11 Journal: International Journal of Environmental Research an [Category] SARS, 변종, [키워드] Alpha variant Analysis attack attack rate calculated can be used Contact coronavirus disease Coronavirus disease 2019 COVID-19 Delta delta variant Delta variants enrolled evaluate household household contact household contacts household transmission Households Increased index case index cases index patient Itako Japan L452R Multivariate analysis Mutation N501Y mutation Patient Prevent Rate Regression model risk factor Risk factors SARS-CoV-2 secondary secondary attack rate spouse Transmission unvaccinated variants wild strain [DOI] 10.3390/ijerph19073889 PMC 바로가기 [Article Type] Article
Pandemic trends in health care use: From the hospital bed to self-care with COVID-19의료 이용의 팬데믹 트렌드: COVID-19와 함께 병상에서 자기 관리까지Article Published on 2022-03-232022-09-11 Journal: PLoS ONE [Category] 변종, [키워드] age Alpha variant Care changed COVID-19 COVID-19 patient delta variant emergency ward First wave General practitioners group Health Health care hospital Hospitalized Norwegian omicron Omicron variant pandemic Patient positive Practitioner SARS-CoV-2 self-care tested with COVID-19 Wuhan strain [DOI] 10.1371/journal.pone.0265812 PMC 바로가기 [Article Type] Article
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2BNT162b2(화이자-바이오엔텍) 및 ChAdOx1 nCoV-19(옥스포드-아스트라제네카) 백신의 SARS-CoV-2 델타 변이형(B.1.617.2) 감염에 대한 감수성 감소 효과Article Published on 2022-03-202022-09-11 Journal: BMC Infectious Diseases [Category] SARS, 변종, 치료기술, [키워드] Action Alpha Alpha variant assumed B.1.1.7 B.1.617.2 BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 Combined Complete Course COVID-19 COVID-19 vaccination programme credible interval delta variant dose doses effective Effectiveness Epidemic explain finding health record Infection Infectious disease intelligence modelling Oxford Oxford-AstraZeneca PCR Pfizer-BioNTech Population predominant provide public health receiving reduce reducing resource SARS-CoV-2 SARS-COV-2 infection single dose Single-dose SIR susceptibility susceptibility to infection symptomatic and asymptomatic Transmission Vaccine variant [DOI] 10.1186/s12879-022-07239-z PMC 바로가기 [Article Type] Article
SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loadsSARS-CoV-2 변종 Delta는 미국에서 변종 Alpha를 빠르게 대체하고 더 높은 바이러스 부하로 이어졌습니다.Article Published on 2022-03-152022-09-11 Journal: Cell Reports Medicine [Category] SARS, 변종, 치료기술, [키워드] accounted Alpha Alpha variant Analysis average collected COVID-19 decrease Delta delta variant dominant variant Gamma Hypothesis Infection Iota majority Mu positive sample quantification SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 variant Sequencing Surveillance the United State Transmissibility United States variant variants Viral load [DOI] 10.1016/j.xcrm.2022.100564 PMC 바로가기 [Article Type] Article
The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster modelSARS-CoV-2 Alpha 변종은 시리아 햄스터 모델의 D614G 균주에 필적할만한 적합성을 나타냅니다.Comparative Study Published on 2022-03-102022-09-11 Journal: Communications Biology [Category] MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] Alpha Alpha variant animal model animals biological properties biological property Bronchial epithelium comparable COVID-19 D614G disease epidemiological situation exhibit experiments highlight Human immune response induce infect involved Laboratory pandemic pathology replaced replicate Replication SARS-CoV-2 SARS-CoV-2 variants Spread strain These data Transmission United Kingdom [DOI] 10.1038/s42003-022-03171-9 PMC 바로가기 [Article Type] Comparative Study
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases사용 가능한 세포 프로테아제에 대한 신속한 SARS-CoV-2 적응Article Published on 2022-03-092022-09-11 Journal: Journal of Virology [Category] SARS, 변종, 유전자 메커니즘, [키워드] adaptation Alpha Alpha variant B.1.1.529 B.1.1.7 B.1.617.2 binding cathepsin Cathepsins cleavage clinical isolates conditions Consensus coronavirus coronavirus spike priming deep sequencing delta variant dominant Efficiency Evolution furin furin cleavage motif furin cleavage site Genome genomes genomic Genotype growth heparan sulfate highlight human cell human cells identify independent inhibit isolate isolates lack mechanism minor motif mutated Omicron variant processed protease Proteases Rapid recent S1/S2 site SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants selection pressure selective sequence spike mutation spike mutation. Spike protein spike protein of SARS-CoV-2 spike variant stability subpopulation sulfate Surveillance the spike protein These cells TMPRSS2 variant variants Vero Vero E6 Vero E6 cell VERO E6 cells virus virus growth virus pathogenesis wild type [DOI] 10.1128/jvi.02186-21 PMC 바로가기 [Article Type] Article
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study미국의 오미크론, 델타 및 알파 SARS-CoV-2 변이체의 covid-19에 대한 mRNA 백신의 임상 중증도 및 효과: 전향적 관찰 연구Observational Study Published on 2022-03-092022-09-11 Journal: The BMJ [Category] SARS, 변종, 임상, [키워드] 95% confidence interval adjusted Alpha Alpha variant calculated case-control study circulating clinical Clinical severity controls delta variant disease severity dose effective Effectiveness group Health Organization hospital Hospital admission Hospital admissions Hospital mortality in-hospital mortality less Lineage morbidity and mortality Mortality mRNA vaccine mRNA vaccines Odds ratio omicron Omicron variant Omicron variants outcome Patient patients predominant Prevent progression prospective observational study provided required SARS-CoV-2 variant Sequencing severe disease severity significantly lower test negative The United States the WHO United States vaccine dose variant variants WHO Clinical Progression Scale whole genome Whole genome sequencing World Health Organization [DOI] 10.1136/bmj-2021-069761 PMC 바로가기 [Article Type] Observational Study